Research Paper Volume 14, Issue 23 pp 9617—9631
A circadian rhythm-related biomarker for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma
Figure 6. Relationship between the newly-established signature with cancer behaviors. (A–C) The signature was linked to these malignant tumor behaviors including invasion and metastasis, while its relationship with proliferation was comparatively weak. (D–F) The newly-established signature was implicated into the levels of hypoxia, EMT as well as angiogenesis (P < 0.05).